ELV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Elevance Health Inc (ELV) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock has strong analyst support, improving sentiment in the managed care sector, and positive developments in its business operations. Despite minor technical weaknesses, the long-term growth potential and favorable analyst ratings outweigh short-term concerns.
The MACD histogram is -3.877, indicating a bearish momentum, and RSI at 32.009 is in the neutral zone but nearing oversold territory. Moving averages are converging, suggesting indecision in the market. Key support levels are at $390.958 and $381.541, with resistance at $406.199 and $421.441. Overall, the technical indicators suggest a cautious entry point.
Analysts have consistently raised price targets, with multiple firms assigning Buy or Overweight ratings.
Positive developments in Medicare Advantage enrollment sanctions and ongoing investments in community health initiatives.
Insider buying activity has increased by 132.13% over the last month, signaling confidence from company insiders.
Hedge funds have increased their selling activity by 135.25% over the last quarter, indicating potential institutional bearishness.
Technical indicators show bearish momentum and indecision, with the stock trading below key pivot levels.
Financial data for the latest quarter is unavailable, but analysts have highlighted favorable Q1 medical cost trends and ongoing margin recovery in government and commercial businesses. These trends suggest a positive growth trajectory.
Analysts are overwhelmingly positive on ELV, with multiple firms raising price targets and maintaining Buy or Overweight ratings. The highest price target is $498, indicating significant upside potential from the current price of $388.48. Analysts cite stabilizing managed care markets, muted cost trends, and AI-driven efficiencies as key growth drivers.
